Endonovo Therapeutics, Inc.
ENDV· OTC
ENDVEndonovo Therapeutics, Inc.
Filed May 21, 2012 · 10-Q · 51 days after period end · 0001469709-12-000113
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Revenue | $1.67K | $0.00 |
| Net Income | -$430.78K | $0.00 |
| EPS Diluted | -$0.01 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Endonovo Therapeutics, Inc. · CIK 1528172 · Engraved from SEC EDGAR
ended Mar 31, 2012 · filed May 21, 2012 · 51 d after period end
